Join the club for FREE to access the whole archive and other member benefits.

BioViva Moving Ahead With Human Gene Therapy for Telomerase Activation

02-Apr-2015

Key points from article :

First company to treat a person with gene therapy to reverse biological aging.

Patient to be monitored every year for 8 years.

May help determine if average telomere length is a marker of the progress of aging or whether telomere lengthening extends life – as seen in mice.

Mentioned in this article:

Click on resource name for more details.

Bioviva Science

Gene therapy innovation leaders developing platforms to treat severe genetic disorders and cellular aging

Liz Parrish

Founder and CEO of BioViva

Topics mentioned on this page:
Gene Therapy